VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹16 Cr | ₹11 Cr | ₹11 Cr | ₹-0.68 Cr | ₹3.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹16 Cr |
Mar2024 | ₹11 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹-0.68 Cr |
Mar2021 | ₹3.63 Cr |
How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹16 Cr | 42.73 | |
Mar2024 | ₹11 Cr | 2.54 | |
Mar2023 | ₹11 Cr | Positive | |
Mar2022 | ₹-0.68 Cr | Negative | |
Mar2021 | ₹3.63 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹606.9 Cr | -2.4% | -0.3% | 36.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | 0.9% | 3.7% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,125.0 Cr | 7.4% | 9% | 8.2% | Stock Analytics | |
CIPLA | ₹125,454.0 Cr | 3.3% | 0.2% | -7.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,106.0 Cr | -0.7% | -1.7% | -0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,263.0 Cr | 1% | -3.2% | -5.2% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -2.4% |
-0.3% |
36.1% |
SENSEX | 0.1% |
0.6% |
0.7% |
You may also like the below Video Courses